Duration up to 12 months
AIP PY4 Activity 3.2. Provide continuous legal support to NHSU with State Reimbursement Program, in line with the Reimbursement Extension Strategy
AIP PY4 Activity 3.5. Improve existing ePrescription set up to further incorporate fraud prevention and detection functions.
Background
In September 2017, the United States Agency for International Development (USAID) awarded a five-year Health Safe, Affordable, and Effective Medicines (SAFEMed) contract to the Management Sciences for Health (MSH). SAFEMed applies health system-strengthening best practices to create evidence-based interventions and strengthen Ukraine’s pharmaceutical system in line with the MOH health care reform objectives. SAFEMed seeks to improve access to appropriate, quality medicines to maximize availability within NHSU budgetary constraints.
SAFEMed interventions will institutionalize rational medicine selection, support sustainable public sector pharmaceutical financing, strengthen and systematize eRx capabilities in collaboration with the Government of Ukraine, the MOH and the NHSU, civil society partners, other implementing partners, and the private sector. In pursuit of its goal, SAFEMed has three primary project objectives:
Since 2016, health care reform in Ukraine has worked to achieve Universal Health Coverage while providing financial protection to its population with quality at its core. Established in 2018, the NHSU is putting together a state-guaranteed benefit package of basic health services. Ukrainian reimbursement program, aka Affordable Medicines, was successfully transferred from MOH to NHSU in 2019. Supported by SAFEMed project the NHSU upgraded medicines reimbursement program to include e-prescription to improve use of public funds, access to care, medicines prescribing practices and consumption monitoring. Inspired by eRx early success and taking into consideration expansion of Ukrainian reimbursement system, NHSU asked SAFEMed to have a deeper investigation of potential areas for ePrescription fraud detection and prevention. As a result of 3-month landscape analysis of the Ukrainian eHealth component related to the reimbursement of the drugs and 5 medical information systems (MIS) interface, SAFEMed developed report for NHSU. The document contains key findings of the assessment, potential fraud scenarios, and clear recommendations for NHSU IT and M&E department to improve eRx antifraud functional. On the later stages SAFEMed invited two consultants to support NHSU capacity and expertise to identify and capture suspicious behavior with eRx. Consultants succeed in development of automatically protocols of data capture, development of eRx storage, and secured priority list fraud scenarios. In 2021 NHSU has an ambitious plan to develop and implement internal, SAP based, ERP system. Establishment of the SAP Financial Services and Contracting modules requires strong integration and interoperability with eHealth central core and should be straightened with additional antifraud protection. Based on previous cooperation experience and a significant progress on the development of ePrescription antifraud functions, NHSU requested SAFEMed to support development and implementation of SAP ERP system by seconding consultant with SAP development background.
Overall Responsibilities
The overall purpose of this consultancy position is to provide experienced design, development, deployment, and operation of the SAP-based ERP system modules, related to the medicines reimbursement system. The consultant will work under guidance and oversight of Ivan Loboda, SAFEMed Principle Technical Advisor.
Functional Responsibilities
Deliverables:
Required Qualifications
Reporting
Consultant will report directly to Mr. Ivan Loboda, SAFEMed Principal Technical Advisor.
Duties performance location
Consultant will work in NHSU, eHealth and/or SAFEMed office in Kyiv, Ukraine with no business trips.
Qualified candidates may apply to the address: [email protected]
Коментарі